Edition:
United States

ARYx Therapeutics Inc (ARYX.PK)

ARYX.PK on OTC Markets Group

0.00USD
18 Aug 2016
Change (% chg)

-- (--)
Prev Close
$0.00
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
7,098
52-wk High
$0.01
52-wk Low
$0.00

ARYX.PK

Chart for ARYX.PK

About

ARYx Therapeutics, Inc. is a United States-based pharmaceutical Company. The Company is developing a proprietary portfolio of patient-targeted, first-in-class monoclonal antibodies designed to treat seriously ill patients with difficult-to-treat diseases. It is engaged in retrometabolic drug design that focuses on the safety of... (more)
No analyst recommendations are available for ARYX.PK.

Overall

Beta: -3.27
Market Cap(Mil.): $0.05
Shares Outstanding(Mil.): 33.46
Dividend: --
Yield (%): --

Financials

  ARYX.PK Industry Sector
P/E (TTM): -- 36.61 36.60
EPS (TTM): -0.61 -- --
ROI: -487.55 14.46 13.91
ROE: -- 15.26 14.82

Competitors

  Price Chg
Johnson & Johnson (JNJ.N) $118.81 -0.65
Pfizer Inc. (PFE.N) $34.26 +0.11
Novartis AG (NOVN.S) CHF79.15 -0.10
Sanofi SA (SASY.PA) €68.45 -0.48
AstraZeneca plc (AZN.L) 5,170.00p +13.00
Bayer AG (BAYGn.DE) €91.48 -0.74
Bayer AG (BAYE.F) -- --
3M Co (MMM.N) $177.39 -2.46
Bristol-Myers Squibb Co (BMY.N) $56.48 +0.06
Bristol-Myers Squibb Co (BMYMP.PK) $985.00 --

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : S&P Capital IQ Quantitative Report
$92.00
Provider : Reuters Investment Profile
$20.00
Provider : GlobalData
$250.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.